APA (7th ed.) Citation

Y, J., G, Y., HC, O., JH, L., E, J., J, B., . . . HH, K. (2026). Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editing. Nature biomedical engineering, 10(7), 1392. https://doi.org/10.1038/s41551-025-01531-4

Chicago Style (17th ed.) Citation

Y, Jung, Yu G, Oh HC, Lee JH, Jeon E, Bae J, Sim T, and Kim HH. "Comprehensive Resistance Profiling of Chronic Myeloid Leukaemia Associated ABL1 Variants Against Five Tyrosine Kinase Inhibitors Using Prime Editing." Nature Biomedical Engineering 10, no. 7 (2026): 1392. https://doi.org/10.1038/s41551-025-01531-4.

MLA (9th ed.) Citation

Y, Jung, et al. "Comprehensive Resistance Profiling of Chronic Myeloid Leukaemia Associated ABL1 Variants Against Five Tyrosine Kinase Inhibitors Using Prime Editing." Nature Biomedical Engineering, vol. 10, no. 7, 2026, p. 1392, https://doi.org/10.1038/s41551-025-01531-4.